Anatara Lifesciences Ltd (ASX:ANR) Directors Insider Transactions



The Directors and Chief Executives of Anatara Lifesciences Ltd (ASX:ANR) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Anatara Lifesciences Ltd's shares in the stock market. Below table shows the list of insider transactions as reported by Anatara Lifesciences Ltd to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Anatara Lifesciences Ltd Directors/Insider Transactions Activity

List of Insider trades activity from Anatara Lifesciences Ltd (ANR).

Date Director Director's Title Shares Value Note
08 Sep 2021 MacLeman (Sue) Director (Non-Executive) 32,259 3,774 Purchase at price 0.12 per share.
30 Jun 2021 Lydeamore (Steven) Chief Executive Officer 200,000 - -